September 2015 Blog Posts (5)

New Anticancer Therapies and Promising Results in Sold Cancers Presented at ECC 2015

A great number of novel anticancer drugs are showing promising results in the treatment of solid cancers. During the biennial European Cancer Congress (ECC 2015) being held in Vienna, Austria (September 25 - 29, 2015), which combines the efforts of the most important European oncology professionals with the aim of improving the prevention, diagnosis, treatment and care of cancer patients, results of ongoing research and new treatment options are presented.

“There are reasons to be…

Continue

Added by Editorial Team on September 28, 2015 at 4:00pm — No Comments

Positive Results from Phase II Trial of ImmunoPulse™ IL-12 in Merkel Cell Carcinoma Presented at European Cancer Congress.

OncoSec Medical, a company developing DNA-based intratumoral cancer immunotherapies, earlier today announced results from OMS-I110 a Phase II clinical trial (NCT01440816) demonstrating that its investigational therapy, ImmunoPulse™ IL-12, promotes tumor-specific, systemic antitumor immune responses in patients with Merkel cell carcinoma…

Continue

Added by Editorial Team on September 28, 2015 at 2:00pm — No Comments

Mediterranean Diet Plus Olive Oil Associated with Reduced Breast Cancer Risk

Eating a Mediterranean diet supplemented with extra virgin olive oil was associated with a relatively lower risk of breast cancer in a study of women in Spain, according to an article published online by JAMA Internal Medicine.[1] 

Breast cancer is a frequently diagnosed cancer and a leading cause of death in women. Diet has been extensively studied as a modifiable risk factor in the development of breast cancer but epidemiologic evidence on the effect of specific dietary…

Continue

Added by Editorial Team on September 14, 2015 at 3:00pm — No Comments

Editorial in Annals of Internal Medicine Shows Medicare’s P4P Incentives Unfairly Penalizing Safety-net Hospitals:

Using unproven, ‘value-based’ penalties and bonuses, and ignoring socioeconomic disparities between patient populations, Medicare is diverting money from hospitals serving largely minority and low-income Americans to hospitals serving the more affluent.

Medicare’s pay-for-performance (P4P) incentives, which financially reward or punish hospitals depending on whether they hit specific numerical targets in matters such as curbing inpatient readmissions, are having the unintended side…

Continue

Added by Editorial Team on September 8, 2015 at 10:30am — No Comments

Increased Risk of MGUS in Vietnam Vets Exposed to Agent Orange

A study that used stored blood samples from U.S. Air Force personnel who conducted aerial herbicide spray missions of Agent Orange during the Vietnam war found a more than 2-fold increased risk of the precursor to multiple myeloma known as monoclonal gammopathy of undetermined significance (MGUS). The study was published in JAMA Oncology. [1]

While the cause of MGUS and multiple myeloma (plasma cell cancer) remains largely unclear, studies have reported an elevated risk of…

Continue

Added by Editorial Team on September 3, 2015 at 11:00pm — No Comments

Monthly Archives

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2005

2004

2001

Register for free to view all the Onco'Zine - The International Oncology Network content:

ADVERTISEMENT/MEDIA PARTNER

Onco'Zine is present here

Bookmark / Share

CONNECT WITH US AND

JOIN THE CONVERSATION


© 2017   Created by Peter Hofland, PhD.   Powered by

Badges  |  Report an Issue  |  Terms of Service

Find us on Google+